FARYDAK (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the FARYDAK drug offered from Novartis Pharmaceuticals Corporation. This Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | panobinostat |
| SUBSTANCE NAME: | PANOBINOSTAT LACTATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-02-23 |
| END MARKETING DATE: | 0000-00-00 |
FARYDAK HUMAN PRESCRIPTION DRUG Details:
| Item Description | FARYDAK from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2015-02-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0650_441444be-7168-4782-8219-c790b8f0bbde |
| PRODUCT NDC: | 0078-0650 |
| APPLICATION NUMBER: | NDA205353 |
Other PANOBINOSTAT LACTATE Pharmaceutical Manufacturers / Labelers:
